Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure

Clinical Cornerstone

Volumn 7, Issue SUPPL. 1, 2005, Pages

  Maisel, Alan S ^a,c   Mehra, Mandeep R ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of California San Diego ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMRINONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; ENALAPRIL; ENOXIMONE; HYDRALAZINE; INOTROPIC AGENT; LOOP DIURETIC AGENT; MILRINONE; MINOXIDIL; NITRATE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM SPARING DIURETIC AGENT; RAMIPRIL; THIAZIDE DIURETIC AGENT; VASOACTIVE AGENT; VASODILATOR AGENT;

ANGIONEUROTIC EDEMA; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST CONTROL; COUGHING; DIAGNOSTIC ACCURACY; DISABILITY; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL; HUMAN; HYPOTENSION; MEDICAL DECISION MAKING; PATIENT MONITORING; PROGNOSIS;

ACUTE DISEASE; BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS; MASS SCREENING; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SYNDROME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 18744414757     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(05)80009-2     Document Type: Article

References (55)

1. American Heart Association Heart Disease and Stroke Statistics - 2003 Update 2002 American Heart Association Dallas, Texas
2. Cohn J.N. Levine T.B. Olivari M.T. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819-823
3. Vinson J.M. Rich M.W. Sperry J.C. et al. Early readmission of elderly patients with heart failure J Am Geriatr Soc 38 1990 1290-1295
4. Krumholz H.M. Wang Y. Parent E.M. et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries Arch Intern Med 157 1997 99-104
5. Stevenson L.W. The limited availability of physical signs for estimating hemodynamics in chronic heart failure JAMA 261 1989 884-888
6. Davie A.P. Francis C.M. Love M.P. et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction BMJ 312 1996 222
7. Deveraux R.B. Liebson P.R. Horan M.J. Recommendations concerning use of echocardiography in hypertension and general population research Hypertension 9 1987 97-104
8. Henry J.P. Pearce J.W. The possible role of cardiac stretch receptors in the induction of changes in urine flow J Physiol 131 1956 572-594
9. De Bold A.J. Borenstein H.B. Veress A.T. Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats Life Sci 28 1981 89-94
10. Kangawa K. Fukuda A. Minamino N. Matsuo H. Purification and complete amino acid sequence of beta-rat atrial natriuretic polypeptide (beta-rANP) of 5000 daltons Biochem Biophys Res Commun 119 1984 933-940
11. Sudoh T. Kangawa K. Minamino N. Matsuo H. A new natriuretic peptide in porcine brain Nature 332 1988 78-81
12. Sudoh T. Minamino N. Kangawa K. Matsuo H. C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain Biochem Biophys Res Commun 168 1990 863-870
13. Minamino N. Makino Y. Tateyama H. et al. Characterization of immunoreactive human C-type natriuretic peptide in brain and heart Biochem Biophys Res Commun 179 1991 535-542
14. Hosoda K. Nakao K. Mukoyama M. et al. Expression of brain natriuretic peptide gene in human heart: Production in the ventricle Hypertension 17 1991 1152-1155
15. Klinge R. Hystad M. Kjekshus J et al. An experimental study of cardiac natriuretic peptides as markers of development of heart failure Scand J Clin Lab Invest 58 1998 683-691
16. Luchner A. Stevens T.L. Borgeson D.D. et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure Am J Physiol 274 1998 H1684-H1689
17. Maeda K. Takayoshi T. Wada A. et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825-832
18. Muders F. Kromer E.P. Griese D.P. et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction Am Heart J 134 1997 442-449
19. Yasue H. Yoshimura M. Sumida H. et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects andpatients with heart failure Circulation 90 1994 195-203
20. Nagagawa O. Ogawa Y. Itoh H. et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an "emergency" cardiac hormoneagainst ventricular overload J Clin Invest 96 1995 1280-1287
21. Grantham J.A. Borgeson D.D. Burnett J.C. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure Am J Physiol 92 1997 R1077-R1083
22. Dao Q. Krishnaswamy P. Kazanegra R. et al. Utility of B-type natriuretic peptide (BNP) in the diagnosis of heart failure in an urgent care setting J Am Coll Cardiol 37 2001 379-385
23. Maisel A.S. Krishnaswamy P. Nowak R.M. et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161-167
24. Wuerz R.C. Meador S.A. Effects of prehospital medications on mortality and length of stay in CHF Ann Emerg Med 21 1992 669-674
25. Maisel A.S. Krishnaswamy P. Nowak R.M. et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161-167
26. Morrison L. Harrison A. Krishnaswamy P. et al. Utility of rapid B-type natriuretic peptide in differentiating congestive heart failure from lung disease J Am Coll Cardiol 39 2002 202-209
27. Maisel A. B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient Rev Cardiovasc Med 3 Suppl 4 2002 S10-S17
28. Mueller C. Scholer A. Laule-Kilian K. et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 2004 647-654
29. McCullough P.A. Nowak R.M. Hollander J.E. et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure Circulation 106 2002 416
30. Maisel A. Hollander J.E. Guss D. et al. for the Rapid Emergency Department Heart Failure Outpatient Trial Investigators Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 2004 1328-1333
31. Harrison A. Morrison L.K. Krishnaswamy P. et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea Ann Emerg Med 39 2002 131-138
32. Wang T.J. Larson M.G. Levy D. et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655-663
33. Atisha D. Bhalla M.A. Morrison L.K. et al. A prospective study in search of an optimal BNP level to screen patients for cardiac dysfunction Am Heart J 148 2004 518-523
34. Heidenreich P.A. Gubens M.A. Fonarow G.C. et al. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019-1026
35. Berger R. Huelsman M. Strecker K. et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392-2397
36. Hunt S.A. Baker D.W. Chin M.H. et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) American College of Cardiology Web site. Available at: http://www.acc.org/ clinical/guidelines/failure/hf_index.htm Accessed January 20, 2005 2001
37. Nohria A. Lewis E. Stevenson L.W. Medical management of advanced heart failure JAMA 287 2002 628-640
38. Latini R. Masson S. Anand I. et al. Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: The Valsartan Heart Failure Trial (Val-HeFT) Circulation 106 2002 2454-2458
39. Richards A.M. Doughty R. Nicholls M.G. et al. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group Circulation 99 1999 786-792
40. Kawai K. Hata K. Takaoka H. et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: A potential of hormone-guided treatment Am Heart J 141 2001 925-932
41. Cheng V.L. Krishnaswamy P. Kazanegra R. et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure J Am Coll Cardiol 37 2001 386-391
42. Bettencourt P. Ferreira S. Azevedo A. Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure Am J Med 113 2002 215-219
43. Tung R.H. Garcia C. Morss A.M. et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock Crit Care Med 32 2004 1643-1647
44. Kazanegra R. Cheng V. Garcia A. et al. A rapid assay for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study J Card Fail. 7 2001 21-29
45. Berman B. Spragg R. Maisel A. B-type natriuretic peptide (BNP) levels in differentiating congestive heart failure from acute respiratory distress syndrome (ARDS) Circulation 106 (Suppl) 2002 II-647
46. Cleland J.G. Erhardt L. Murray G. et al. for the AIRE Study Investigators Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators Eur Heart J. 18 1997 41
47. Troughton R.W. Frampton C.M. Yandle T.G. et al. Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126-1130
48. Tsutamoto T. Wada A. Maeda K. et al. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure J Am Coll Cardiol 37 2001 1228-1233
49. Anand I.S. Lloyd D. Chiang Y.T. et al. for the Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT) Circulation 107 2003 1278-1283
50. Lee S.C. Stevens T.L. Sandberg S.M. et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure J Card Fail. 8 2002 149-154
51. Bhalla V. Willis S. Maisel A.S. B-type natriuretic peptide: The level and the drug - partners in the diagnosis of congestive heart failure Congest Heart Fail 10 2004 3-27
52. de Lemos J.A. Morrow D.A. Bentley J.H. et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014-1021
53. Sabatine M.S. Morrow D.A. de Lemos J.A. et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactiveprotein, and B-type natriuretic peptide Circulation 105 2002 1760-1763
54. Morrow D.A. de Lemos J.A. Sabatine M.S. et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/ non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol 41 2003 1264-1272 [published correction appears in: J Am Coll Cardiol. 2003;41:1852]
55. Jiang C.Y. Li N. Wang J.A. Use of B-type natriuretic peptide in evaluation of early percutaneous coronary intervention in patients with acute coronary syndrome Chin Med J (Engl) 117 2004 1130-1134